The metabolic features of normal pancreas and pancreatic adenocarcinoma: Preliminary result of in vivo proton magnetic resonance spectroscopy at 3.0 T

Journal of Computer Assisted Tomography

Volumn 35, Issue 5, 2011, Pages 539-544

  Ma, Xiaohong ^a   Zhao, Xinming ^a   Ouyang, Han ^a   Sun, Fei ^b   Zhang, Hongmei ^a   Zhou, Chunwu ^a   Shen, Hao ^c  

^a CANCER HOSPITAL   (China)

^b Shanghai Guided Medical Scientific Co Ltd   (China)

^c GE HEALTHCARE   (United Kingdom)

Author keywords

choline; lipid; magnetic resonance spectroscopy; pancreas; pancreatic adenocarcinoma

Indexed keywords

BIOMARKERS; DISEASES; FATTY ACIDS; METABOLISM; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BREATH-HOLD; CHOLINE; IN-VIVO; PANCREAS; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCERS; PANCREATIC HEAD CANCERS; PROTON MAGNETIC RESONANCE SPECTROSCOPIES; STATISTICAL DIFFERENCES;

MAGNETISM;

ANISODAMINE; BIOLOGICAL MARKER; CHOLINE; FATTY ACID; LIPID; WATER;

ADULT; AGED; ARTICLE; BREATH HOLDING; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; WHOLE BODY MRI;

EID: 80053039884     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318227a545     Document Type: Article

References (33)

1. Schima W, Ba-Ssalamah A, Kölblinger C, et al. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638-649.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2006;56:106-130.
3. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20:1218-1249. (Pubitemid 43727584)
4. Kaplan O, Kushnir T, Askenazy N, et al. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer. Cancer Res. 1997;57:1452-1459. (Pubitemid 27175560)
5. Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders [review]. Arch Neurol. 1999;56:919-926. (Pubitemid 29374808)
6. Shukla-Dave A, Hricak H, Eberhardt SC, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology. 2004;231:717-724. (Pubitemid 38668088)
7. Chawla S, Wang S, Wolf RL, et al. Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol. 2007;28:1683-1689. (Pubitemid 47598140)
8. Lai PH, Weng HH, Chen CY, et al. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging. AJNR Am J Neuroradiol. 2008;29:1511-1518.
9. Stanwell P, Mountford C. In vivo proton MR spectroscopy of the breast. Radiographics. 2007;27(suppl 1):S253-S266.
10. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: Preliminary study. Radiology. 2006;239:686-692. (Pubitemid 43830603)
11. Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: A review. Liver Int. 2008;28:297-307. (Pubitemid 351279577)
12. Scheenen TWJ, Heijmink SWTPJ, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: Feasibility. Radiology. 2007;245:507-516. (Pubitemid 47612533)
13. Fang F, He XH, Deng HW, et al. Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis. Cancer Sci. 2007;98:1678-1682. (Pubitemid 47487900)
14. Cho SG, Lee DH, Lee KY, et al. Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2005;29:163-169. (Pubitemid 40411298)
15. Bredella MA, Ghomi RH, Thomas BJ, et al. Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 tesla. J Comput Assist Tomogr. 2010;34:372-376.
16. Erturk SM, Alberich-Bayarri A, Herrmann KA, et al. Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics. 2009;29:1547-1563.
17. Chang KJ, Kamel IR, Macura KJ, et al. 3.0-T MR imaging of the abdomen: Comparison with 1.5 T. Radiographics. 2008;28:1983-1998.
18. Fischbach F, Schirmer T, Thormann M, et al. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 tesla. Eur Radiol. 2008;18:2549-2558.
19. Kuo YT, Li CW, Chen CY, et al. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0 T MR scanner. J Magn Reson Imaging. 2004;19:598-604.
20. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12: 413-439. (Pubitemid 30016999)
21. Shah N, Sattar A, Benanti M, et al. Magnetic resonance spectroscopy as an imaging tool for cancer: A review of the literature. JAOA. 2006;106:23-26.
22. Bartella L, Huang W. Proton (1H) MR spectroscopy of the breast. Radiographics. 2007;27(suppl 1):S241-S252.
23. Faria JF, Goldman SM, Szejnfeld J, et al. Adrenal masses: Characterization with in vivo proton MR spectroscopy-initial experience. Radiology. 2007;245:788-797. (Pubitemid 350127349)
24. Nikolaus M, Loening AM, Chamberlin AG, et al. Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. NMR Biomed. 2005;18:413-420.
25. Bali MA, Metens T, Denolin V, et al. Pancreatic perfusion: Noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers-initial results. Radiology. 2008;247:115-121.
26. Ahrén B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia. 2000;43:393-410. (Pubitemid 30237947)
27. Gilon P, Henquin JC. Mechanism and physiological significance of the cholinergic control of pancreatic A-cell function [review]. Endocrine. 2001;22:565-604. (Pubitemid 32958576)
28. Ilcol YO, Gurun MS, Taga Y, et al. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated acetylcholine release from the rat minced pancreas in vitro. Eur J Biochem. 2003;270:991-999. (Pubitemid 36315342)
29. Kern SE, Hruban RH, Hidalgo M, et al. An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol Ther. 2002;1:607-613.
30. Morvan D, Demidem A, Papon J, et al. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: Demonstration of phospholipids metabolism alterations. Magn Reson Med. 2003;49:241-248. (Pubitemid 36159860)
31. Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging. Radiology. 2002;223:91-97. (Pubitemid 34258194)
32. Schwarz AJ, Maisey NR, Collins DJ, et al. Early in vivo detection of metabolic response: A pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours. Br J Radiol. 2002;75:959-966. (Pubitemid 36149760)
33. Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo 1H MR spectroscopy-A pilot study at 4 T. Radiology. 2004;233:424-431. (Pubitemid 39423801)